Equities

Lexaria Bioscience Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LEXX:NAQ

Lexaria Bioscience Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.71
  • Today's Change0.011 / 1.57%
  • Shares traded488.80k
  • 1 Year change-51.70%
  • Beta0.5366
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Monday, Lexaria Bioscience Corp (LEXX:NAQ) closed at 0.71, 54.35% above the 52 week low of 0.46 set on Dec 26, 2025.
52-week range
Today
0.46Dec 26 20251.90Mar 24 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.6705
High0.7197
Low0.6422
Bid0.6704
Offer0.7199
Previous close0.699
Average volume149.77k
Shares outstanding24.89m
Free float23.30m
P/E (TTM)--
Market cap17.40m USD
EPS (TTM)-0.5743
USD
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼

Events & Activity

  • LEXX:NAQ price moved over -5.02% to 0.6824
  • LEXX:NAQ price rises above 50-day moving average to 0.6998 at 20:19 GMT
  • LEXX:NAQ trading volume exceeds daily average by +21.74%
  • LEXX:NAQ price falls below 50-day moving average to 0.7011 at 16:15 GMT
  • LEXX:NAQ price rises above 50-day moving average to 0.7199 at 15:12 GMT
  • LEXX:NAQ price falls below 15-day moving average to 0.6505 at 14:31 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.